Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11, ... Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11, leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.04 | -3.38983050847 | 1.18 | 1.27 | 1.1 | 14025 | 1.21465536 | CS |
| 4 | -0.26 | -18.5714285714 | 1.4 | 1.52 | 1.03 | 24378 | 1.23977239 | CS |
| 12 | -0.52 | -31.3253012048 | 1.66 | 2.03 | 1.03 | 133256 | 1.63410594 | CS |
| 26 | -0.26 | -18.5714285714 | 1.4 | 2.64 | 1.03 | 1678831 | 1.82725532 | CS |
| 52 | -10.785 | -90.4402515723 | 11.925 | 12.2775 | 1.03 | 1307738 | 3.27319874 | CS |
| 156 | -18.86 | -94.3 | 20 | 31.5 | 1.03 | 636182 | 6.21978754 | CS |
| 260 | -18.86 | -94.3 | 20 | 31.5 | 1.03 | 636182 | 6.21978754 | CS |
| Symbol | Preis | Vol. |
|---|---|---|
| SOXLDirexion Daily Semiconductor Bull 3X Shares | US$ 16,03 (-9,74%) | 138,23M |
| MSTUT Rex 2X Long MSTR Daily Target ETF | US$ 5,52 (-21,70%) | 87,94M |
| TSLZT Rex 2X Inverse Tesla Daily Target ETF | US$ 4,065 (7,26%) | 81,5M |
| SPXSDirexion Daily S&P 500 Bear 3X Shares New | US$ 7,25 (6,30%) | 81,15M |
| SPYSPDR S&P 500 | US$ 555,66 (-2,01%) | 71,66M |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
